Dual Biologic Therapy in a Pregnant Patient With Crohn&#39;s Disease and Axial Spondyloarthritis

Remicade (infliximab) - J&J

Cimzia (certolizumab pegol) - Astellas, UCB

Humira (adalimumab) - AbbVie

Tremfya (guselkumab) - J&J

Stelara (ustekinumab) - J&J

Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim

Simponi (golimumab) - J&J

Rinvoq (upadacitinib) - AbbVie

mercaptopurine - Generic mfg.

Entyvio (vedolizumab) - Takeda

Kevin Martz DO 1; M. Anthony Sofia MD 2

Aug 29, 2026